Subscribe

The Conversations
We Should Have Had

Bill Gibson

October 28, 2025

9 Minute Read

Read More

Articles

October 28, 2025
9 Minute Read

The Conversations We Should Have Had: A Personal and Professional Journey Through Alzheimer’s Disease

Bill Gibson
October 23, 2025
9 Minute Read

Women’s Health, GLP-1s and ‘AI Everywhere’ Drive the Conversation at HLTH 2025

Multiple Authors
October 15, 2025
11 Minute Read

‘Health Above All’: A Q&A With Lilly’s Jennifer Oleksiw

Chase Feiger
October 9, 2025
13 Minute Read

‘Not Playing a Role Isn’t an Option’: Meredith Gannon’s Missions to Transform Marketing and Maternal Care

Larry Dobrow
October 1, 2025
6 Minute Read

‘We Sought the Asset Out’: Inside Iterum’s Race to Reshape the UTI Treatment Market

Larry Dobrow
September 25, 2025
12 Minute Read

Same Question, Different Answer: Fixing AI Wobble in Pharma

Ahmed Elsayyad
September 17, 2025
8 Minute Read

AI Hype, Meet Humanity: Takeaways From Fierce Pharma Week 2025

Multiple Authors
September 12, 2025
13 Minute Read

The Mechanics of Pharma M&A: A Q&A With Gilead’s Devang Bhuva

Chase Feiger
September 4, 2025
12 Minute Read

5 Ways AI Will Reshape Pharma Marketing—And 5 Reasons It Will Matter to HCPs

Zach Capetola
August 21, 2025
11 Minute Read

How GPT-5 Will (and Won’t) Change Pharma Marketers’ Lives

Ahmed Elsayyad
August 14, 2025
9 Minute Read

It’s 2025. Women’s Health Still Isn’t a Priority.

Meg Rivera
August 8, 2025
11 Minute Read

Leading with Authenticity in the Rare Disease Space: A Q&A with Ascendis’ Jay Donovan Wu

Chase Feiger
Load More

Kinara